首页> 外文期刊>Nucleic Acids Research >Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells
【24h】

Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells

机译:永生人类细胞中端粒酶成分和hTERT mRNA剪接模式的定量

获取原文
获取原文并翻译 | 示例
           

摘要

Telomerase is a reverse transcriptase that adds telomeric repeats to chromosomal ends. In most normal human somatic cells, telomerase is repressed and telomeres progressively shorten, leading to limited proliferative life-span. Telomerase reactivation is associated with cellular immortalization and is a frequent event during tumorigenesis. The telomerase ribonucleoprotein complex consists of two essential components, a catalytic protein subunit [human telomerase reverse transcriptase (hTERT)] and a template RNA (hTR). hTR is constitutively expressed, while hTERT is almost universally absent in telomerase-negative cells. Although repression of telomerase is transcriptional in telomerase-negative cells, posttranscriptional and assembly processes are likely to play important roles in regulating telomerase activity in those that are telomerase-positive. The telomerase transcript can also be alternatively spliced into a variety of non-functional forms. To establish the quantitative relationships between telomerase activity and its various components, we determined the numbers of molecules of hTR and hTERT mRNA, and the levels of alternatively spliced hTERT mRNA variants in normal, in vitro immortalized and cancer cell lines. We report here that there is surprisingly little variation in the proportion of alternatively spliced forms of hTERT in different cell lines. The only variation observed occurred when a change in splicing to non-functional forms appeared in response to conditions that repress telomerase activity in IDH4 cells. We also found that most telomerase-positive cell lines only contain a few molecules of potentially functional hTERT mRNA, and there is a correlation between telomerase activity and the levels of both hTR and hTERT +α+β mRNA.
机译:端粒酶是一种逆转录酶,可在染色体末端添加端粒重复序列。在大多数正常的人类体细胞中,端粒酶被抑制,端粒逐渐缩短,导致增殖寿命有限。端粒酶再激活与细胞永生化有关,并且是肿瘤发生期间的常见事件。端粒酶核糖核蛋白复合物由两个基本成分组成:催化蛋白亚基[人端粒酶逆转录酶(hTERT)]和模板RNA(hTR)。 hTR组成型表达,而hTERT在端粒酶阴性细胞中几乎普遍不存在。尽管抑制端粒酶在端粒酶阴性细胞中是转录的,但转录后和组装过程可能在调节端粒酶阳性的端粒酶活性中起重要作用。端粒酶转录物也可以选择性地剪接成各种非功能形式。为了建立端粒酶活性与其各种成分之间的定量关系,我们确定了正常,体外永生化和癌细胞系中hTR和hTERT mRNA的分子数量,以及交替剪接的hTERT mRNA变异体的水平。我们在这里报告,在不同细胞系中,hTERT的可变剪接形式所占比例几乎没有变化。当响应抑制IDH4细胞端粒酶活性的条件而出现剪接成非功能形式的变化时,观察到的唯一变化发生了。我们还发现,大多数端粒酶阳性细胞系仅包含少量可能具有功能的hTERT mRNA分子,并且端粒酶活性与hTR和hTERT +α+βmRNA的水平之间存在相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号